Effects on Subacute Stroke With Robotic Assistive Gait Training
Launched by CHANGHUA CHRISTIAN HOSPITAL · Jun 26, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using a special robotic device to help with walking, combined with regular physical therapy, can improve walking ability and overall function in people who have recently had a stroke. The participants will be adults who had a stroke within the past 1 to 3 months and who have moderate to good balance and can follow instructions. People with other serious health problems, heavy weight over 90 kg, or severe pain or stiffness in their legs won’t be eligible.
If you take part, you will be randomly assigned to receive either both robotic-assisted walking training and traditional physical therapy, or just the traditional physical therapy alone. The study will then check how well you walk and perform daily activities during the treatment period. This trial aims to find out if adding robotic help to regular therapy makes a meaningful difference in recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with stroke (ischemic or hemorrhagic) confirmed by medical imaging.
- • Subacute phase of stroke (onset within 1 to 3 months).
- • Moderate to good standing balance ability.
- • Sufficient cognitive ability to understand the study and follow instructions.
- • Able to participate in rehabilitation training during the study period.
- Exclusion Criteria:
- • Body weight over 90 kg.
- • Presence of other neurological disorders.
- • Severe cardiovascular disease or other health conditions affecting mobility.
- • Significant lower limb pain, joint contracture, or spasticity (Modified Ashworth Scale score \> 3) that impairs walking.
- • Diagnosed with cardiopulmonary disease that contraindicates exercise training.
- • Cognitive impairment that prevents understanding of training instructions or completion of questionnaires.
- • Inability to complete the rehabilitation training protocol.
About Changhua Christian Hospital
Changhua Christian Hospital is a leading healthcare institution in Taiwan, renowned for its commitment to advancing medical research and patient care. Established with a mission to provide comprehensive and compassionate healthcare services, the hospital actively engages in clinical trials aimed at enhancing treatment protocols and improving patient outcomes. With a strong emphasis on collaboration and innovation, Changhua Christian Hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate cutting-edge research across various medical fields. The hospital is dedicated to upholding the highest ethical standards in clinical research while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changhua, , Taiwan
Patients applied
Trial Officials
Su-Fen Liao
Principal Investigator
Changhua Christian Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported